Order
      
      140401-05-4
      
        4-Hexenoicacid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-,2-(4-morpholinyl)ethyl ester, (E)-
      
    
    
    
    
    
      
        Order
      
      132758-27-1
      
        (3Z)-5-acetyl-6-hydroxy-3-{1-[(2-phenylethyl)amino]ethylidene}-2H-pyran-2,4(3H)-dione
      
    
    
    
    
    
    
    
      
        Order
      
      140400-59-5
      
        2-Butene-1,4-diol,2-[2-[1,2,3,4,4a,7,8,8a-octahydro-4-hydroxy-4a-(hydroxymethyl)-1,2,5-trimethyl-1-naphthalenyl]ethyl]-,[1S-[1a(Z),2b,4b,4ab,8aa]]-
      
    
    
      
        Order
      
      136910-27-5
      
        L-Lysine,N6-[6-[[5-[(3aS,4S,6aR)-hexahydro- 2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1- oxopentyl]amino]-1-oxohexyl]-
      
    
    
    
      
        Order
      
      140402-47-7
      
        2-Thiopheneacetic acid, 5-(4-fluorophenyl)-4-[4-(methylsulfonyl)phenyl]-,methyl ester
      
    
    
    
    
    
    
    
                    
  
  
  
  
  
  
  
  
                136910-09-3,136910-27-5,136911-16-5,136912-19-1,140400-59-5,140400-67-5 Supplier | KINGPHARM.GROUP
            CMO CDMO service. KINGPHARM.GROUP supply 136910-09-3,136910-27-5,136911-16-5,136912-19-1,140400-59-5,140400-67-5 and related compounds.
            
                    136910-09-3
                    140400-67-5
                    136911-16-5
                    136910-27-5
                    140400-59-5
                    136912-19-1